Zeria

Moderna and Gavi update COVAX supply deal to include variant-specific COVID-19 vaccines

The Omicron-adapted booster has also received authorisations in the UK, Europe, Australia, Canda, Japan, South Korea, Switzerland, Singapore and Taiwan to date.

Shionogi signs licence agreement with MPP for COVID-19 oral antiviral treatment

The emergency approval of ensitrelvir was deliberated in the Pharmaceutical Affairs and Food Sanitation Council meeting held in July 2022 in Japan, and review will continue based on the results of

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

A total of 1, 821 predominantly vaccinated patients were enrolled in Japan, South Korea and Vietnam, irrespective of risk factors for COVID-19 progression. ... Japan and the US Food and Drug Administration (FDA), based on their scientific and medical

Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study

Eisai outlined that it will discuss the data with regulatory authorities in the US, Japan and Europe, and aims to file for traditional approval in the US, as well as marketing ... authorisation applications in Japan and Europe, by 2023.

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment

In April 2022 Ultomiris was approved in the US and, in the same year, was then approved in Japan for certain adults with gMG.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]